Thursday, 18 April 2024
Trending

[the_ad_group id="2845"]

Investing

The Eurofins Network Expands Its Offering in Renal and Transplant Testing in the United States With the Acquisition of Ascend Clinical LLC

Pinterest Climbs 2.25% By Investing.com

[the_ad id="21475"]

[ad_1]

LUXEMBOURG–(BUSINESS WIRE)–Regulatory News:

Eurofins Scientific (EUFI.PA), a global leader in bioanalytical testing, announces the closing of its acquisition of Ascend Clinical, LLC (Ascend), the largest independent laboratory for kidney dialysis testing in the United States. Founded in 2000, Ascend operates a state-of-the-art laboratory in Sunnyvale, California and employs 170 staff. The company provides highly automated chemistry, hematology, microbiology and virology testing services to dialysis clinics and hospitals across the United States. The company also offers water and dialysate testing, providing greater safety to the dialysis patient community and facilitating successful regulatory audits and surveys. Ascend’s core competencies and client relationships complement the Eurofins network’s extensive portfolio of pre- and post-transplant services, which will result in better and broader service offerings to clients.

The acquisition further reinforces the Eurofins network’s footprint in transplant testing and associated renal care, broadening its clinical client base. Ascend, in return, gains access to Eurofins’ extensive laboratory network, analytical portfolio, and established industry relationships. Patti Hunsader, the current COO of Ascend, will assume the role of President of Ascend Clinical. The existing leadership of the company will remain in place, continuing to drive the organisation’s growth as part of the Eurofins clinical diagnostics business line in the United States.

Comment from Dr. Gilles Martin, Eurofins CEO: “This transaction further extends our efforts to provide best in class testing care to patients in the renal and transplantation fields. We look forward to providing Ascend’s clients with access to the capabilities of the Eurofins network, and to support Ascend in strengthening and growing the important services they provide to patients.

Comment from Patti Hunsader, Ascend COO: “We are excited to join forces with the Eurofins network. This partnership creates exciting opportunities to leverage our combined expertise and resources to positively impact the lives of the patients we serve.”

Integrating Ascend’s expertise and client base with Eurofins’ geographic reach, technological capabilities and expertise will elevate the standard of care provided for patients nationwide.

Notes to Editors:

About Eurofins “ the global leader in bio-analysis

Eurofins is Testing for Life. The Eurofins Scientific S.E. network of…

Click Here to Read the Full Original Article at All News…

[ad_2]

[the_ad id="21476"]